Targeting the Functional Cure: The Journey of HBV from Transmission to Therapeutic Vaccines
Background: Hepatitis B Virus (HBV) infection affects 262 million people worldwide, leading to over 820,000 deaths annually. The reason HBV has been a persistent issue for decades is that it is a non-cytopathic, liver-specific virus with the ability for persistent infection, which cannot be completely eliminated by dr...